DiagnosTear Technologies Inc. Announces Warrant Extension
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company") announces that it has extended the expiry date of 5,733,885 outstanding common share purchase warrants (the "November 2024 Warrants") and 133,333 outstanding common share purchase warrants (the "December 2024 Warrants"). The November 2024 Warrants were issued in connection with a non-brokered private placement of subscription r
2026-05-04 8:30 AM EDT | DiagnosTear Technologies Inc.
Red Light Holland Announces Intention to Rebrand
New name and branding to be announced in the coming weeks, better aligned with the Company's scientific mandate and all business segments Name change resolution to be voted on by shareholders at the upcoming Annual General and Special Meeting ("AGSM") on May 11, 2026 Company urges all shareholders to vote IN FAVOUR of the name change resolution to support the rebranding exercise Rebranding reflects the combined focus on clinical research, GMP
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-05-04 8:30 AM EDT | Red Light Holland Corp.
QScreen AI Reports Internal Validation Results for Correctional Intake Platform: 100% Sensitivity on Suicide Risk and Withdrawal Detection Across 65 Calibrated Clinical Scenarios
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening today reports internal validation results for its correctional intake platform across 65 calibrated clinical scenarios tested against published instrument thresholds. By digitizing the high-liability blind spots of correctional intake, QAI transforms a universal institutional risk into a scalable Saa
2026-05-04 7:03 AM EDT | QScreen AI Inc.
Promino Nutritional Sciences Reports Fiscal 2025 Results, Delivering Revenue Growth and Improved Financial Performance
Burlington, Ontario--(Newsfile Corp. - May 4, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a performance nutrition company focused on clinically validated amino acid formulations, today announced its audited financial results for the year ended December 31, 2025. Fiscal 2025 Financial Highlights Revenue of over $2.1 million, compared to approximately $260,600 in 2024
Aliments / boissons, Sports, Santé
2026-05-04 7:00 AM EDT | Promino Nutritional Sciences, Inc.
Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, announces that it has filed on SEDAR+ and completed the mailing of its notice of annual and special meeting, management information circular and related meeting materials (collectively, the "Mee
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-05-01 8:04 AM EDT | Neural Therapeutics Inc.
Three Finalists Announced for the 2026 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Bloom Burton & Co. ("Bloom Burton") is thrilled to announce the finalists for the 2026 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2026, in alphabetical order, are: Ian Mortimer, President & Chief Executive Officer, Xenon Ph
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-05-01 7:30 AM EDT | Bloom Burton & Co. Inc.
Edison Issues Report on Abcourt Mines (ABI)
London, United Kingdom--(Newsfile Corp. - May 1, 2026) - Edison issues report on Abcourt Mines (TSXV: ABI). Abcourt Mines is in the process of ramping up its Sleeping Giant mine in the Abitibi region of Quebec. To date, this ramp up has been exclusively focused on room-and-pillar stopes. However, Abcourt commissioned its first long-hole stope this month and expects it to be in production in early summer, after which the pace of ramp up should increase materially, allowing the mine to ac
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-05-01 7:11 AM EDT | Edison Group
Safe Supply Streaming Co Ltd. Completes Rebranding to Altrova Health Inc., with Common Shares Now Trading Under New Ticker Symbol ROVA on the CSE
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: SSPLF) (FSE: QM4) (formerly Safe Supply Streaming Co Ltd.) ("Altrova Health" or the "Company") announces the completion of its corporate rebranding and the commencement of trading of its common shares under the new name and ticker symbol "ROVA" on the Canadian Securities Exchange ("CSE"), effective today. Corporate Name and Ticker Change The name and ticker c
2026-05-01 7:07 AM EDT | Altrova Health Inc.
Beckett's Secures US$500,000 in Convertible Debenture Financing and Files 2025 Fiscal Year-End Results
Ontario and Los Angeles, California--(Newsfile Corp. - May 1, 2026) - Beckett's Inc. (CSE: BKTS) ("Beckett's" or the "Company") announces that it intends to complete a secured debt financing raising gross proceeds of US$500,000 by way of issuance of 5-Year 8% Secured Convertible Debentures (the "Debentures"). The principal amount of the Debentures will bear interest at a rate of 8% per annum and will have a term of five (5) years. Subject to regulatory ap
Aliments / boissons, Cannabis, Santé
2026-05-01 7:00 AM EDT | Becketts Inc.
Dr. Christina Rahm Recognized Nationally for Building Patent-Driven Manufacturing Behind The ROOT Brands Products
Franklin, Tennessee--(Newsfile Corp. - April 30, 2026) - Dr. Christina Rahm, scientist, inventor, and Founder and Chief Science Officer of The ROOT Brands, has received a Gold Stevie® Award in the 2026 American Business Awards® for Building and Scaling Patent-Driven Manufacturing Infrastructure (M
Biotechnologies, Aliments / boissons, Santé
2026-04-30 4:45 PM EDT | DRC Ventures
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical Synthesis™ platform, today announced that it will report its first quarter 2026 financial results before the market opening on Thursday, May 14, 2026. The Company will also host a conference call and webcast at 8:00 a.m. U.S. Eastern Time to discuss the results and provide
Biotechnologies, Pharmaceutique, Santé
2026-04-30 4:05 PM EDT | BioHarvest Sciences Inc.
LevelJump Announces Delay in Filing Annual Financial Statements
Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), a leading provider of teleradiology and diagnostic imaging services, wishes to advise its shareholders that, despite the best efforts of the Company, there will be a delay in the filing of its annual financial statements and management discussion and analysis for the period ending December 31, 2025 (the "Required Filings"). Based on the current status of the audi
Soins de santé et hôpitaux, Santé
2026-04-30 4:05 PM EDT | LevelJump Healthcare Corp.
Restart Life Advances Holy Crap Growth Strategy with New Protein SKU Nearing Commercialization
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide an update on its collaboration with the University of Manitoba's Richardson Centre for Food Technology and Research (RCFTR), announcing the development of a new protein-focused SKU under its Holy Crap™ brand. This initiative extends the Company's existing research collaboration with RCFTR and
Technologies, Biotechnologies, Santé
2026-04-30 8:00 AM EDT | Restart Life Sciences Corp.
Glow Lifetech Expands Distribution with Two of Canada's Largest Cannabis Retailers, Launches New Product Innovation and Advances National Growth Strategy
Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a commercial update highlighting continued expansion of its retail distribution network, new product innovation, and progress advancing its national growth strategy. MOD™ Expands into Two of Canada's Largest Cannabis Retailers Building on Glow's recent success expanding distribution with Canada's
2026-04-30 7:30 AM EDT | Glow Lifetech Corp.
Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution
Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distribution Adds Filament's extensive intellectual property portfolio, including 70+ patents and proprietary extraction technologies Leverages Health Canada Dealer's License and FDA-aligned clinical development pathways, including IND-enabled activities Positions the Company at the forefront of the rapidly emerging regu
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-30 7:30 AM EDT | Red Light Holland Corp.
FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, announces that it has entered into an agreement dated April 28, 2026, with Innovotech Labs Corporation ("Innovotech") (TSXV: IOT) (OTCQB: IOTCF) to support regulatory planning for its coated catheter program. U
Technologies, Soins de santé et hôpitaux, Santé
2026-04-29 6:00 PM EDT | FendX Technologies Inc.
TempraMed Announces Continuance into Ontario
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has continued out of the provincial jurisdiction of British Columbia under the Business Corporations Act (British Columbia) into the provincial jurisdiction of Ontario under the
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-04-29 4:30 PM EDT | TempraMed Technologies Ltd.
Akanda Adjourns Special Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today convened and subsequently adjourned its Special Meeting of Shareholders (the "Meeting") without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person in Toronto, Ontario on Monday, May 25, 2026 at 10:00 a.m. (Eastern Time). The adjournment provides the Company wi
Cannabis, Santé, Cultivateurs de cannabis, Producteurs de cannabis
2026-04-29 8:30 AM EDT | Akanda Corp
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis™ technology, today announced a s
Biotechnologies, Pharmaceutique, Santé
2026-04-29 8:30 AM EDT | BioHarvest Sciences Inc.
Izotropic Africa Launches Operations in Casablanca
British Columbia and Casablanca, Morocco--(Newsfile Corp. - April 29, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces the official launch of Izotropic Africa in Casablanca, Morocco, and th
2026-04-29 8:00 AM EDT | Izotropic Corporation